Voloridge Investment Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-45,437
| Closed | -$333K | – | 1304 |
|
|
2025
Q1 | $333K | Buy |
45,437
+11,954
| +36% | +$87.6K | ﹤0.01% | 1119 |
|
|
2024
Q4 | $286K | Sell |
33,483
-83,499
| -71% | -$713K | ﹤0.01% | 1128 |
|
|
2024
Q3 | $1.02M | Sell |
116,982
-572,035
| -83% | -$4.98M | ﹤0.01% | 1021 |
|
|
2024
Q2 | $4.71M | Sell |
689,017
-397,777
| -37% | -$2.72M | 0.02% | 763 |
|
|
2024
Q1 | $9.89M | Buy |
+1,086,794
| New | +$9.89M | 0.04% | 494 |
|
|
2022
Q2 | – | Sell |
-174,967
| Closed | -$866K | – | 1572 |
|
|
2022
Q1 | $866K | Sell |
174,967
-134,750
| -44% | -$667K | ﹤0.01% | 1160 |
|
|
2021
Q4 | $2.16M | Buy |
309,717
+242,211
| +359% | +$1.69M | 0.01% | 1044 |
|
|
2021
Q3 | $675K | Buy |
+67,506
| New | +$675K | ﹤0.01% | 1390 |
|
|
2021
Q1 | – | Sell |
-24,060
| Closed | -$498K | – | 1578 |
|
|
2020
Q4 | $498K | Buy |
+24,060
| New | +$498K | ﹤0.01% | 1125 |
|